Medicine & Life Sciences
Belgium
100%
HIV
90%
Syphilis
82%
Sexually Transmitted Diseases
72%
Neisseria gonorrhoeae
69%
Sexual and Gender Minorities
68%
Pre-Exposure Prophylaxis
61%
Gonorrhea
60%
South Africa
58%
Macrolides
45%
Treponema pallidum
40%
Neisseria
37%
Fluoroquinolones
30%
Mycoplasma genitalium
28%
Chlamydia
27%
Azithromycin
24%
Infection
22%
Sexual Partners
22%
Sexual Behavior
22%
Population
21%
Ciprofloxacin
19%
Kenya
18%
Chrysosporium
18%
Mycoses
17%
Mouthwashes
16%
Risk-Taking
15%
Bacterial Vaginosis
15%
Onygenales
14%
Cephalosporins
14%
Blastomyces
14%
Epidemics
14%
Fungi
13%
HIV Infections
13%
Quinolones
13%
Systematic Reviews
12%
Heterosexuality
11%
Cohort Studies
11%
Human Herpesvirus 2
11%
Microbial Drug Resistance
10%
Horizontal Gene Transfer
10%
Linear Models
10%
Ecosystem
10%
Acquired Immunodeficiency Syndrome
10%
Chlamydia trachomatis
10%
Epidemiology
9%
Neisseria meningitidis
9%
Guidelines
9%
Ceftriaxone
9%
Incidence
9%
Cryptococcus neoformans
9%
Urease
8%
Anti-Bacterial Agents
8%
Chlorhexidine
8%
Globus Pallidus
8%
Ethiopia
8%
Uganda
8%
Proteome
8%
Mutation
8%
Blastomycosis
8%
Uncertainty
7%
Cross-Sectional Studies
7%
Whole Genome Sequencing
7%
Urine
7%
Reagins
7%
Ribosomal Proteins
7%
SARS Virus
7%
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
6%
Genes
6%
Sexual Health
6%
Animals
6%
Mass Spectrometry
6%
Polymerase Chain Reaction
6%
Antimicrobial Stewardship
6%
Confidence Intervals
6%
Observational Studies
6%
Therapeutics
6%
Africa South of the Sahara
6%
Syndemic
6%
Monkeypox virus
6%
Southern Africa
6%
Streptococcus pneumoniae
5%
Lymphogranuloma Venereum
5%
Escherichia coli
5%
Oropharynx
5%
Biomarkers
5%
Primary Health Care
5%
Eastern Africa
5%
Neurosyphilis
5%
Fungal Spores
5%
Trichomonas vaginalis
5%
Greenland
5%
Male Circumcision
5%
Mycology
5%
Microbiota
5%
Feathers
5%
Skin
5%
Logistic Models
5%
Immune Reconstitution Inflammatory Syndrome
5%
Post-Exposure Prophylaxis
5%